
Gyan Chandra
Examiner (ID: 3544, Phone: (571)272-2922 , Office: P/1646 )
| Most Active Art Unit | 1646 |
| Art Unit(s) | 1674, 1646 |
| Total Applications | 1422 |
| Issued Applications | 816 |
| Pending Applications | 139 |
| Abandoned Applications | 480 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6658381
[patent_doc_number] => 20030133972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-17
[patent_title] => 'Targeted multivalent macromolecules'
[patent_app_type] => new
[patent_app_number] => 10/159596
[patent_app_country] => US
[patent_app_date] => 2002-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 34686
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0133/20030133972.pdf
[firstpage_image] =>[orig_patent_app_number] => 10159596
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/159596 | Targeted multivalent macromolecules | May 29, 2002 | Abandoned |
Array
(
[id] => 6855722
[patent_doc_number] => 20030129223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Targeted multivalent macromolecules'
[patent_app_type] => new
[patent_app_number] => 10/158777
[patent_app_country] => US
[patent_app_date] => 2002-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 34634
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20030129223.pdf
[firstpage_image] =>[orig_patent_app_number] => 10158777
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/158777 | Targeted multivalent macromolecules | May 29, 2002 | Abandoned |
| 10/031490 | Combined preparations comprising antitumor agents | May 9, 2002 | Abandoned |
Array
(
[id] => 6725047
[patent_doc_number] => 20030207359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-06
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/141756
[patent_app_country] => US
[patent_app_date] => 2002-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 551
[patent_figures_cnt] => 551
[patent_no_of_words] => 63542
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20030207359.pdf
[firstpage_image] =>[orig_patent_app_number] => 10141756
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/141756 | PRO4409 polypeptides | May 7, 2002 | Issued |
Array
(
[id] => 6696290
[patent_doc_number] => 20030108484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Individualization of therapy with antineoplastic agents'
[patent_app_type] => new
[patent_app_number] => 10/135185
[patent_app_country] => US
[patent_app_date] => 2002-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 42967
[patent_no_of_claims] => 83
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20030108484.pdf
[firstpage_image] =>[orig_patent_app_number] => 10135185
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/135185 | Individualization of therapy with antineoplastic agents | Apr 28, 2002 | Abandoned |
Array
(
[id] => 711553
[patent_doc_number] => 07057021
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-06
[patent_title] => 'Genes encoding caspase recruitment domain polypeptides'
[patent_app_type] => utility
[patent_app_number] => 10/133780
[patent_app_country] => US
[patent_app_date] => 2002-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 24703
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/057/07057021.pdf
[firstpage_image] =>[orig_patent_app_number] => 10133780
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/133780 | Genes encoding caspase recruitment domain polypeptides | Apr 25, 2002 | Issued |
Array
(
[id] => 6739742
[patent_doc_number] => 20030157111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => '76A11 polypeptide and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/128736
[patent_app_country] => US
[patent_app_date] => 2002-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13621
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20030157111.pdf
[firstpage_image] =>[orig_patent_app_number] => 10128736
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/128736 | 76A11 polypeptide and uses thereof | Apr 22, 2002 | Abandoned |
Array
(
[id] => 728644
[patent_doc_number] => 07041643
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-09
[patent_title] => 'Molecules of the PYRIN/NBS/LRR protein family and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/124498
[patent_app_country] => US
[patent_app_date] => 2002-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 62338
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/041/07041643.pdf
[firstpage_image] =>[orig_patent_app_number] => 10124498
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/124498 | Molecules of the PYRIN/NBS/LRR protein family and uses thereof | Apr 16, 2002 | Issued |
Array
(
[id] => 7296072
[patent_doc_number] => 20040214248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Use of semenogelin in the diagnosis, prognosis and treatment of cancer'
[patent_app_type] => new
[patent_app_number] => 10/474213
[patent_app_country] => US
[patent_app_date] => 2004-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8266
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214248.pdf
[firstpage_image] =>[orig_patent_app_number] => 10474213
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/474213 | Use of semenogelin in the diagnosis, prognosis and treatment of cancer | Apr 2, 2002 | Issued |
Array
(
[id] => 7408929
[patent_doc_number] => 20040019915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-29
[patent_title] => 'Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer'
[patent_app_type] => new
[patent_app_number] => 10/114432
[patent_app_country] => US
[patent_app_date] => 2002-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 61
[patent_no_of_words] => 192045
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20040019915.pdf
[firstpage_image] =>[orig_patent_app_number] => 10114432
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/114432 | Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer | Mar 31, 2002 | Abandoned |
Array
(
[id] => 800394
[patent_doc_number] => 07425538
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-16
[patent_title] => 'HAUSP-p53 interaction and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/113732
[patent_app_country] => US
[patent_app_date] => 2002-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 9
[patent_no_of_words] => 19619
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/425/07425538.pdf
[firstpage_image] =>[orig_patent_app_number] => 10113732
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/113732 | HAUSP-p53 interaction and uses thereof | Mar 29, 2002 | Issued |
Array
(
[id] => 6847063
[patent_doc_number] => 20030166230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Methods and compositions for modulating tumor suppression'
[patent_app_type] => new
[patent_app_number] => 10/107521
[patent_app_country] => US
[patent_app_date] => 2002-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 12735
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166230.pdf
[firstpage_image] =>[orig_patent_app_number] => 10107521
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/107521 | Methods and compositions for modulating tumor suppression | Mar 24, 2002 | Issued |
Array
(
[id] => 6651026
[patent_doc_number] => 20030105002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'RGS compositions and therapeutic and diagnostic uses therefor'
[patent_app_type] => new
[patent_app_number] => 10/105004
[patent_app_country] => US
[patent_app_date] => 2002-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 36863
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20030105002.pdf
[firstpage_image] =>[orig_patent_app_number] => 10105004
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/105004 | RIEG compositions and therapeutic and diagnostic uses therefor | Mar 21, 2002 | Issued |
Array
(
[id] => 6830308
[patent_doc_number] => 20030181366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Peptide inhibitors of Akt and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/103256
[patent_app_country] => US
[patent_app_date] => 2002-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7161
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20030181366.pdf
[firstpage_image] =>[orig_patent_app_number] => 10103256
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/103256 | Peptide inhibitors of Akt and uses thereof | Mar 20, 2002 | Abandoned |
Array
(
[id] => 654454
[patent_doc_number] => 07108973
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-19
[patent_title] => 'Human PEN11B-related gene variant associated with lung cancers'
[patent_app_type] => utility
[patent_app_number] => 10/102548
[patent_app_country] => US
[patent_app_date] => 2002-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 3584
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/108/07108973.pdf
[firstpage_image] =>[orig_patent_app_number] => 10102548
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/102548 | Human PEN11B-related gene variant associated with lung cancers | Mar 19, 2002 | Issued |
Array
(
[id] => 6797459
[patent_doc_number] => 20030176333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'CASPR3: modulators of angiogenesis'
[patent_app_type] => new
[patent_app_number] => 10/100818
[patent_app_country] => US
[patent_app_date] => 2002-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 18399
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20030176333.pdf
[firstpage_image] =>[orig_patent_app_number] => 10100818
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/100818 | CASPR3: modulators of angiogenesis | Mar 17, 2002 | Abandoned |
Array
(
[id] => 623187
[patent_doc_number] => 07138122
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-11-21
[patent_title] => 'Therapeutic systems'
[patent_app_type] => utility
[patent_app_number] => 10/099830
[patent_app_country] => US
[patent_app_date] => 2002-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 21
[patent_no_of_words] => 20184
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/138/07138122.pdf
[firstpage_image] =>[orig_patent_app_number] => 10099830
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/099830 | Therapeutic systems | Mar 12, 2002 | Issued |
Array
(
[id] => 6774175
[patent_doc_number] => 20030017513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Insulin-like growth factor system and cancer'
[patent_app_type] => new
[patent_app_number] => 10/092769
[patent_app_country] => US
[patent_app_date] => 2002-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10480
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20030017513.pdf
[firstpage_image] =>[orig_patent_app_number] => 10092769
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/092769 | Insulin-like growth factor system and cancer | Mar 6, 2002 | Abandoned |
Array
(
[id] => 7180486
[patent_doc_number] => 20050124549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Method of modulating the proliferation of medullary thyroid carcinoma cells'
[patent_app_type] => utility
[patent_app_number] => 10/469835
[patent_app_country] => US
[patent_app_date] => 2002-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8443
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20050124549.pdf
[firstpage_image] =>[orig_patent_app_number] => 10469835
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/469835 | Method of modulating the proliferation of medullary thyroid carcinoma cells | Mar 5, 2002 | Abandoned |
Array
(
[id] => 5845283
[patent_doc_number] => 20020132778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'Modulating angiogenesis'
[patent_app_type] => new
[patent_app_number] => 10/068591
[patent_app_country] => US
[patent_app_date] => 2002-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6495
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20020132778.pdf
[firstpage_image] =>[orig_patent_app_number] => 10068591
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/068591 | Modulating angiogenesis | Feb 5, 2002 | Issued |